mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.5 |